MedTech 2017 Annual Conference comes to Sydney next month
The MedTech 2017 Annual Conference, hosted by the Medical Technology Association of Australia (MTAA), will take place from 1–2 November at Doltone House, Jones Bay Wharf, Sydney.
The event provides an opportunity for industry professionals to gather and exchange ideas and insights with peers and other leaders in the medical technology community. The theme this year is ‘The Value of Medical Technology to a Healthier Australia’, highlighting how Australia’s medtech industry is playing a critical role in producing healthier, more productive populations.
Sessions of interest include:
- Artificial Intelligence in Healthcare the Here and Now
- The Future Buyers: Does valued-based healthcare have a place?
- How Blockchain will transform healthcare in 25 Years
- Tomorrow’s Jobs
The event is also set to feature an impressive line-up of national and international guest speakers. The opening address will be presented by NSW Minister for Health and Medical Research Brad Hazzard, while Assistant Minister for Health Dr David Gillespie will present the session ‘Tele-health: Improving care, delivery and outcomes’. International guests include Dr Dora Hughes, Former Health Advisor to US President Barack Obama, and Richie Etwaru, Chief Digital Officer of multinational company QuintilesIMS.
The MedTech 2017 Industry Awards Dinner, to be held at the conclusion of the first day, will bring together industry leaders, suppliers and clients to celebrate and pay tribute to a year of innovation and leadership. The winners will be announced for the inaugural Women in MedTech Champion, the Kerrin Rennie Award, the 2017 Outstanding Achievement Award and other awards of recognition.
The MTAA has advised that registration is closing soon and the event is on track to reach capacity, so those interested in attending are encouraged to register now at https://medtech2017.mtaa.org.au/. Potential exhibitors are meanwhile asked to contact Jennifer Ellis, MTAA events & engagement manager, at jellis@mtaa.org.au.
A pre-emptive approach to treating leukaemia relapse
The monitoring of measurable residual disease (MRD), medication and low-dose chemotherapy is...
Long COVID abnormalities appear to resolve over time
Researchers at UNSW's Kirby Institute have shown that biomarkers in long COVID patients have...
RNA-targeted therapy shows promise for childhood dementia
Scientists have shown that a new RNA-targeted therapy can halt the progression of a specific type...
